Axsome Settles Patent Litigation With Hikma Related To Sunosi - Quick Facts

(RTTNews) - Axsome Therapeutics (AXSM) has entered into a settlement agreement with Hikma Pharmaceuticals USA, Inc. resolving patent litigation related to Axsomes product Sunosi or solriamfetol. Axsome will grant Hikma a license to sell its generic version of Sunosi beginning on https://www.nasdaq.com/articles/axsome-settles-patent-litigation-hikma-related-sunosi-quick-facts